Anti-hepcidin therapy for iron-restricted anemias.
Anti-hepcidin therapy for iron-restricted anemias.
复制标题
DOI：
10.1182/blood-2013-08-522466
复制
发表时间：
2013-10
期刊：
影响因子：
20.3
通讯作者：
E. Nemeth
中科院分区：
文献类型：
--
作者：
E. Nemeth
In this issue of Blood, Cooke et al demonstrate the potential of a fully human anti-hepcidin antibody as a novel therapeutic for iron-restricted anemias such as anemia of inflammation, cancer, or chronic kidney disease (formerly known as “anemia of chronic diseases”).
